Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AgeX Therapeutics Q1 EPS $(0.07) Down From $(0.05) YoY, Sales $5.00K Down From $56.00K YoY

Author: Benzinga Newsdesk | May 13, 2022 04:06pm
AgeX Therapeutics (AMEX:AGE) reported quarterly losses of $(0.07) per share. This is a 40 percent decrease over losses of $(0.05) per share from the same period last year. The company reported $5.00 thousand in sales this quarter. This is a 91.07 percent decrease over sales of $56.00 thousand the same period last year.

Posted In: AGE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist